Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. 
We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases.
Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success will provide rapid validation of our ALIGATER platform.



Biotechnology

Coave Therapeutics

Coave Therapeutics' headquarters in PARIS, France

Description

People (6)

Rodolphe Clerval

Julien Berger

Lavaniya Kunalingam

Delphine Compere

Maxime Jarrin

Gaelle M. Lefevre

Jobs